Modrykamien Ariel M, Gupta Pooja
Division of Pulmonary and Critical Care Medicine, Baylor University Medical Center at Dallas, Dallas, Texas (Modrykamien), and the Division of Pulmonary, Sleep, and Critical Care Medicine, Creighton University Medical Center, Omaha, Nebraska (Gupta).
Proc (Bayl Univ Med Cent). 2015 Apr;28(2):163-71. doi: 10.1080/08998280.2015.11929219.
The acute respiratory distress syndrome (ARDS) is a major cause of acute respiratory failure. Its development leads to high rates of mortality, as well as short- and long-term complications, such as physical and cognitive impairment. Therefore, early recognition of this syndrome and application of demonstrated therapeutic interventions are essential to change the natural course of this devastating entity. In this review article, we describe updated concepts in ARDS. Specifically, we discuss the new definition of ARDS, its risk factors and pathophysiology, and current evidence regarding ventilation management, adjunctive therapies, and intervention required in refractory hypoxemia.
急性呼吸窘迫综合征(ARDS)是急性呼吸衰竭的主要原因。其发展会导致高死亡率以及短期和长期并发症,如身体和认知功能障碍。因此,早期识别该综合征并应用已证实的治疗干预措施对于改变这种毁灭性疾病的自然病程至关重要。在这篇综述文章中,我们描述了ARDS的最新概念。具体而言,我们讨论了ARDS的新定义、其危险因素和病理生理学,以及关于通气管理、辅助治疗和难治性低氧血症所需干预措施的当前证据。